P-230 Is stereotactic microwave ablation of resectable colorectal liver metastasis an alternative for liver resection in the Covid-19 pandemic?

Abstract

Liver resection for resectable colorectal liver metastasis is still considered the standard local therapy. Recent studies showed no difference in overall survival between microwave ablation and resection of liver metastasis with a diameter less than 3 cm. Ablation by percutaneous approach and under CT guidance is considered less invasive than open or laparoscopic resection or ablation. On the other hand, percutaneous ablation by “free-hand” puncture is considered less accurate, potentially resulting in higher incomplete ablation and local recurrence rates.